Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Hematoma | Research article

Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis

Authors: Mineaki Kitamura, Yohei Tateishi, Shuntaro Sato, Satoko Kitamura, Yuki Ota, Kumiko Muta, Hiroshi Yamashita, Tadashi Uramatsu, Yoko Obata, Yasushi Mochizuki, Masaharu Nishikido, Tsuyoshi Izumo, Takashi Harada, Satoshi Funakoshi, Takayuki Matsuo, Akira Tsujino, Hideki Sakai, Hiroshi Mukae, Tomoya Nishino

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

High serum calcium levels should be avoided in patients on hemodialysis (HD) because they can induce cardiovascular diseases and worsen the patient’s prognosis. In contrast, low serum calcium levels worsen the prognosis of patients with cerebral hemorrhage in the general population. So far, whether serum calcium levels in patients on HD are associated with cerebral hemorrhage remains unknown. This study aimed to reveal the association between serum calcium and cerebral hemorrhage in patients on HD, including in-hospital death, volume of hematoma, and onset of cerebral hemorrhage.

Methods

This cross-sectional case-control study included 99 patients on HD with cerebral hemorrhage at a single center between July 1, 2007 and December 31, 2017. Controls included 339 patients on HD at a single HD center between July 1, 2011 and June 30, 2012. Data on serum calcium level, patient demographics, and comorbid conditions were collected, and associations between cerebral hemorrhage and subsequent death were evaluated by multivariate logistic regression analysis. Further, the association of these backgrounds and hematoma volume was evaluated by multiple regression analysis.

Results

Of the 99 patients, 32 (32%) died from cerebral hemorrhage. The corrected serum calcium level (odds ratio [OR], 2.49; 95% confidence interval [CI], 1.43–4.35; P < 0.001) and antiplatelet drug use (OR, 3.95; 95% CI, 1.50–10.4; P = 0.005) had significant effects on the prognosis. Moreover, the corrected serum calcium (P = 0.003) and antiplatelet drug use (P = 0.01) were significantly correlated with hematoma volume. In the patients, the corrected serum calcium level (OR, 1.54; 95% CI, 1.07–2.22; P = 0.02) was associated with the onset of cerebral hemorrhage, as was pre-hemodialysis systolic blood pressure (per 10 mmHg) (OR, 1.40; 95% CI, 1.23–1.59; P < 0.001).

Conclusions

Although the precise mechanisms remain unknown, a high serum calcium level is associated with cerebral hemorrhage in patients on HD. Thus, we should pay attentions to a patient’s calcium level.
Appendix
Available only for authorised users
Literature
1.
go back to reference Drew DA, Sarnak MJ. Ischemic and hemorrhagic stroke: high incidence in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. National Kidney Foundation, Inc.; 2014;63:547–8.CrossRef Drew DA, Sarnak MJ. Ischemic and hemorrhagic stroke: high incidence in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. National Kidney Foundation, Inc.; 2014;63:547–8.CrossRef
2.
go back to reference Power A, Chan K, Singh SK, Taube D, Duncan N. Appraising stroke risk in maintenance hemodialysis patients: a large single-center cohort study. Am J Kidney Dis. Elsevier Inc.; 2012;59:249–57.CrossRef Power A, Chan K, Singh SK, Taube D, Duncan N. Appraising stroke risk in maintenance hemodialysis patients: a large single-center cohort study. Am J Kidney Dis. Elsevier Inc.; 2012;59:249–57.CrossRef
3.
go back to reference Kawamura M, Fijimoto S, Hisanaga S, Yamamoto Y, Eto T. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am J Kidney Dis. 1998;31:991–6.CrossRef Kawamura M, Fijimoto S, Hisanaga S, Yamamoto Y, Eto T. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am J Kidney Dis. 1998;31:991–6.CrossRef
4.
go back to reference Herrington W, Haynes R, Staplin N, Emberson J, Baigent C, Landray M. Evidence for the prevention and treatment of stroke in dialysis patients. Semin Dial. 2015;28:35–47.CrossRef Herrington W, Haynes R, Staplin N, Emberson J, Baigent C, Landray M. Evidence for the prevention and treatment of stroke in dialysis patients. Semin Dial. 2015;28:35–47.CrossRef
5.
go back to reference Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int. 1993;44:1086–90.CrossRef Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int. 1993;44:1086–90.CrossRef
6.
go back to reference Wakasugi M, Matsuo K, Kazama JJ, Narita I. Higher mortality due to intracerebral hemorrhage in dialysis patients: a comparison with the general population in Japan. Ther Apher Dial. 2015;19:45–9.CrossRef Wakasugi M, Matsuo K, Kazama JJ, Narita I. Higher mortality due to intracerebral hemorrhage in dialysis patients: a comparison with the general population in Japan. Ther Apher Dial. 2015;19:45–9.CrossRef
7.
go back to reference Toyoda K, Fujii K, Fujimi S, Kumai Y, Tsuchimochi H, Ibayashi S, et al. Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis. 2005;45:1058–66.CrossRef Toyoda K, Fujii K, Fujimi S, Kumai Y, Tsuchimochi H, Ibayashi S, et al. Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis. 2005;45:1058–66.CrossRef
8.
go back to reference Wang HH, Hung SY, Sung JM, Hung KY, Wang JD. Risk of stroke in long-term dialysis patients compared with the general population. Am J Kidney Dis. 2014;63:604–11.CrossRef Wang HH, Hung SY, Sung JM, Hung KY, Wang JD. Risk of stroke in long-term dialysis patients compared with the general population. Am J Kidney Dis. 2014;63:604–11.CrossRef
9.
go back to reference Yamada S, Tsuruya K, Taniguchi M, Tokumoto M, Fujisaki K, Hirakata H, et al. Association between serum phosphate levels and stroke risk in patients undergoing hemodialysis: the Q-cohort study. Stroke. 2016;47:2189–96.CrossRef Yamada S, Tsuruya K, Taniguchi M, Tokumoto M, Fujisaki K, Hirakata H, et al. Association between serum phosphate levels and stroke risk in patients undergoing hemodialysis: the Q-cohort study. Stroke. 2016;47:2189–96.CrossRef
10.
go back to reference Sakamoto N, Ishikawa E, Aoki K, Uemae Y, Komatsu Y, Matsumura A. Clinical outcomes of intracerebral hemorrhage in hemodialysis patients. World Neurosurg Elsevier Inc. 2014;81:538–42.CrossRef Sakamoto N, Ishikawa E, Aoki K, Uemae Y, Komatsu Y, Matsumura A. Clinical outcomes of intracerebral hemorrhage in hemodialysis patients. World Neurosurg Elsevier Inc. 2014;81:538–42.CrossRef
11.
go back to reference Yotsueda R, Tanaka S, Taniguchi M, Fujisaki K, Torisu K, Masutani K, et al. Hemoglobin concentration and the risk of hemorrhagic and ischemic stroke in patients undergoing hemodialysis: the Q-cohort study. Nephrol Dial Transplant. 2017:1–9. Yotsueda R, Tanaka S, Taniguchi M, Fujisaki K, Torisu K, Masutani K, et al. Hemoglobin concentration and the risk of hemorrhagic and ischemic stroke in patients undergoing hemodialysis: the Q-cohort study. Nephrol Dial Transplant. 2017:1–9.
12.
go back to reference Tagawa M, Hamano T, Nishi H, Tsuchida K, Hanafusa N, Fukatsu A, et al. Mineral metabolism markers are associated with myocardial infarction and hemorrhagic stroke but not ischemic stroke in hemodialysis patients: a longitudinal study. PLoS One. 2014;9:1–16.CrossRef Tagawa M, Hamano T, Nishi H, Tsuchida K, Hanafusa N, Fukatsu A, et al. Mineral metabolism markers are associated with myocardial infarction and hemorrhagic stroke but not ischemic stroke in hemodialysis patients: a longitudinal study. PLoS One. 2014;9:1–16.CrossRef
13.
go back to reference Spiegel DM, Brady K. Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets. Kidney Int. 2012;81:1116–22.CrossRef Spiegel DM, Brady K. Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets. Kidney Int. 2012;81:1116–22.CrossRef
14.
go back to reference Nakano C, Hamano T, Fujii N, Matsui I, Tomida K, Mikami S, et al. Combined use of vitamin D status and FGF23 for risk stratification of renal outcome. Clin J Am Soc Nephrol. 2012;7:810–9.CrossRef Nakano C, Hamano T, Fujii N, Matsui I, Tomida K, Mikami S, et al. Combined use of vitamin D status and FGF23 for risk stratification of renal outcome. Clin J Am Soc Nephrol. 2012;7:810–9.CrossRef
15.
go back to reference Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2008;52:519–30.CrossRef Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2008;52:519–30.CrossRef
16.
go back to reference Moe SM, Drueke TB. Group for the KW. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention and treatment of chronic kidney disease mineral and bone disorder (CKD-MBD). Kidney Int. 2017;76:S1–128. Moe SM, Drueke TB. Group for the KW. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention and treatment of chronic kidney disease mineral and bone disorder (CKD-MBD). Kidney Int. 2017;76:S1–128.
17.
go back to reference Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al. Executive summary of the 2017 KDIGO chronic kidney disease–mineral and bone disorder (CKD-MBD) guideline update: what’s changed and why it matters. Kidney Int. 2017;92:26–36.CrossRef Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al. Executive summary of the 2017 KDIGO chronic kidney disease–mineral and bone disorder (CKD-MBD) guideline update: what’s changed and why it matters. Kidney Int. 2017;92:26–36.CrossRef
18.
go back to reference Inoue Y, Miyashita F, Toyoda K, Minematsu K. Low serum calcium levels contribute to larger hematoma volume in acute intracerebral hemorrhage. Stroke. 2013;44:2004–6.CrossRef Inoue Y, Miyashita F, Toyoda K, Minematsu K. Low serum calcium levels contribute to larger hematoma volume in acute intracerebral hemorrhage. Stroke. 2013;44:2004–6.CrossRef
19.
go back to reference You S, Han Q, Xu J, Zhong C, Zhang YY, Liu H, et al. Serum calcium and phosphate levels and short- and long-term outcomes in acute intracerebral hemorrhage patients. J Stroke Cerebrovasc Dis. 2016;25:914–20.CrossRef You S, Han Q, Xu J, Zhong C, Zhang YY, Liu H, et al. Serum calcium and phosphate levels and short- and long-term outcomes in acute intracerebral hemorrhage patients. J Stroke Cerebrovasc Dis. 2016;25:914–20.CrossRef
20.
go back to reference Morotti A, Charidimou A, Phuah C-L, Jessel MJ, Schwab K, Ayres AM, et al. Association between serum calcium level and extent of bleeding in patients with intracerebral hemorrhage. JAMA Neurol. 2016;73:1285.CrossRef Morotti A, Charidimou A, Phuah C-L, Jessel MJ, Schwab K, Ayres AM, et al. Association between serum calcium level and extent of bleeding in patients with intracerebral hemorrhage. JAMA Neurol. 2016;73:1285.CrossRef
21.
go back to reference Helweg-Larsen S, Sommer W, Strange P, Lester J, Boysen G. Prognosis for patients treated conservatively for spontaneous intracerebral hematomas. Stroke. 1984;15:1045–8.CrossRef Helweg-Larsen S, Sommer W, Strange P, Lester J, Boysen G. Prognosis for patients treated conservatively for spontaneous intracerebral hematomas. Stroke. 1984;15:1045–8.CrossRef
22.
go back to reference Falcone GJ, Biffi A, Brouwers HB, Anderson CD, Battey TWK, Ayres AM, et al. Predictors of hematoma volume in deep and lobar supratentorial intracerebral hemorrhage. JAMA Neurol. 2013;70:988–94.CrossRef Falcone GJ, Biffi A, Brouwers HB, Anderson CD, Battey TWK, Ayres AM, et al. Predictors of hematoma volume in deep and lobar supratentorial intracerebral hemorrhage. JAMA Neurol. 2013;70:988–94.CrossRef
23.
go back to reference Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage a powerful and easy-to-use predictor of 30-day mortality. 1993;987–93. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage a powerful and easy-to-use predictor of 30-day mortality. 1993;987–93.
24.
go back to reference Brott T, Jr HPA, Olinger CP, Marler JR, Barsan WG. Biller J, et al. Measurements of Acute cerebral infarction. 2016;1:864–71. Brott T, Jr HPA, Olinger CP, Marler JR, Barsan WG. Biller J, et al. Measurements of Acute cerebral infarction. 2016;1:864–71.
25.
go back to reference Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke. 1999;30:1538–41.CrossRef Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke. 1999;30:1538–41.CrossRef
26.
go back to reference Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J. 1973;4:643–6.CrossRef Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J. 1973;4:643–6.CrossRef
27.
go back to reference Yoshida T, Hayashi M. Anemia treatment by erythropoiesis-stimulating agents during the 6 months before the initiation of hemodialysis: comparison of darbepoetin alfa and continuous erythropoietin receptor activator. Keio J Med. 2017;66:44–50.CrossRef Yoshida T, Hayashi M. Anemia treatment by erythropoiesis-stimulating agents during the 6 months before the initiation of hemodialysis: comparison of darbepoetin alfa and continuous erythropoietin receptor activator. Keio J Med. 2017;66:44–50.CrossRef
28.
go back to reference O’Neill WC. Targeting serum calcium in chronic kidney disease and end-stage renal disease: is normal too high? Kidney Int. 2016;89:40–5.CrossRef O’Neill WC. Targeting serum calcium in chronic kidney disease and end-stage renal disease: is normal too high? Kidney Int. 2016;89:40–5.CrossRef
29.
go back to reference Marín J, Encabo A, Briones A, Garcí̈a-Cohen EC, Alonso MJ. Mechanisms involved in the cellular calcium homeostasis in vascular smooth muscle: Calcium pumps Life Sci 1999;64:279–303. Marín J, Encabo A, Briones A, Garcí̈a-Cohen EC, Alonso MJ. Mechanisms involved in the cellular calcium homeostasis in vascular smooth muscle: Calcium pumps Life Sci 1999;64:279–303.
30.
go back to reference Brown RC, Davis TP. Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke. 2002;33:1706–11.CrossRef Brown RC, Davis TP. Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke. 2002;33:1706–11.CrossRef
31.
go back to reference Kyriazis J, Glotsos J, Bilirakis L, Smirnioudis N, Tripolitou M, Georgiakodis F, et al. Dialysate calcium profiling during hemodialysis: use and clinical implications. Kidney Int. 2002;61:276–87.CrossRef Kyriazis J, Glotsos J, Bilirakis L, Smirnioudis N, Tripolitou M, Georgiakodis F, et al. Dialysate calcium profiling during hemodialysis: use and clinical implications. Kidney Int. 2002;61:276–87.CrossRef
32.
go back to reference Drüeke TB, Touam M. Calcium balance in haemodialysis - do not lower the dialysate calcium concentration too much (con part). Nephrol Dial Transplant. 2009;24:2990–3.CrossRef Drüeke TB, Touam M. Calcium balance in haemodialysis - do not lower the dialysate calcium concentration too much (con part). Nephrol Dial Transplant. 2009;24:2990–3.CrossRef
33.
go back to reference Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Gutiérrez OM, et al. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2017;70:737–51.CrossRef Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Gutiérrez OM, et al. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2017;70:737–51.CrossRef
34.
go back to reference Pereira L, Meng C, Marques D, Frazão JM. Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes. Clin Kidney J. 2018;11:80–8.CrossRef Pereira L, Meng C, Marques D, Frazão JM. Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes. Clin Kidney J. 2018;11:80–8.CrossRef
35.
go back to reference He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. J Am Med Assoc. 1998;280:1930–5.CrossRef He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. J Am Med Assoc. 1998;280:1930–5.CrossRef
36.
go back to reference Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke. 2009;40:2398–401.CrossRef Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke. 2009;40:2398–401.CrossRef
37.
go back to reference The Nagasaki Regional Council for Renal Failure. Annual data reports of the patients on renal replacement therapy in Nagasaki Prefecture. 2007–2016, not available on web site. p. not available. The Nagasaki Regional Council for Renal Failure. Annual data reports of the patients on renal replacement therapy in Nagasaki Prefecture. 2007–2016, not available on web site. p. not available.
Metadata
Title
Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis
Authors
Mineaki Kitamura
Yohei Tateishi
Shuntaro Sato
Satoko Kitamura
Yuki Ota
Kumiko Muta
Hiroshi Yamashita
Tadashi Uramatsu
Yoko Obata
Yasushi Mochizuki
Masaharu Nishikido
Tsuyoshi Izumo
Takashi Harada
Satoshi Funakoshi
Takayuki Matsuo
Akira Tsujino
Hideki Sakai
Hiroshi Mukae
Tomoya Nishino
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1400-4

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue